While diabetes has reached the proportions of an epidemic in many countries across the world, India will soon be able to lay claim to the dubious distinction of being its global capital. India is on target to have close to 100 million diabetics within the next 25 years, and unless drastic changes are made and innovative ventures undertaken to rein in the epidemic, the economic and social fallout will be nothing short of catastrophic. The consequences of diabetes in India are particularly dire because of a number of unique factors including population, genetics, rapid socio-economic upheavals and the lack of public healthcare infrastructure.
GHI in India
In response to such growing concerns, we propose a scalable, self-sustaining business plan that focuses on providing community-level diabetes monitoring services to individuals in their homes and neighborhoods. Such a localized service model approach enables diabetes patients and people at risk of developing diabetes to measure and record their blood glucose levels in a way that is both affordable and accessible to them. It is hoped that such testing will reduce the long-terms socio-economic implications of the many debilitating diseases associated with diabetes, help to relieve some of the pressure of the creaking public health infrastructure, and bring about a substantial improvement in the lives of diabetics in India.
Critical to the success of this project are partnerships on the ground in India, particularly those with Dr. Srikanta and the Jnana Sanjeevini Medical Center (JS) in Bangalore. This charitable hospital treats diabetes and other endocrine disorders to all patients regardless of income. Our team and JS hope to soon collaborate in order to pilot the aforementioned service model with the hopes of ultimately scaling it to different urban, peri-urban and/or rural communities across India.